Maverick Capital Ltd. Acquires 1,208,296 Shares of Acadia Healthcare Company, Inc. $ACHC

Key Points

• Maverick Capital Ltd. increased its stake in Acadia Healthcare by 116.3%, owning approximately 2.44% (2,246,923 shares) worth $68.1 million as of the end of the latest quarter.
• Acadia Healthcare reported $0.83 earnings per share (EPS) for the latest quarter, exceeding estimates, with a revenue increase of 9.2% year-over-year.
• Wall Street analysts largely maintain a positive outlook on Acadia Healthcare, with an average price target of $40.77 and ratings reflecting a "Moderate Buy."

Maverick Capital Ltd. increased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 116.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,246,923 shares of the company's stock after purchasing an additional 1,208,296 shares during the period. Maverick Capital Ltd. owned approximately 2.44% of Acadia Healthcare worth $68,127,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. UMB Bank n.a. grew its position in Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after acquiring an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its position in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after acquiring an additional 1,234 shares during the last quarter. State of Wyoming bought a new position in Acadia Healthcare in the fourth quarter valued at about $56,000. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 56.0% during the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock valued at $69,000 after purchasing an additional 812 shares in the last quarter. Finally, Aquatic Capital Management LLC acquired a new stake in shares of Acadia Healthcare during the fourth quarter valued at about $97,000.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock traded up $0.07 during trading on Friday, hitting $23.72. 2,018,492 shares of the stock traded hands, compared to its average volume of 2,215,601. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of 15.71, a PEG ratio of 4.59 and a beta of 0.89. The firm's fifty day moving average is $22.17 and its 200-day moving average is $25.05. Acadia Healthcare Company, Inc. has a 52 week low of $17.13 and a 52 week high of $79.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period in the prior year, the company earned $0.91 EPS. The company's revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Barclays cut their price objective on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 7th. Cowen reissued a "buy" rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Guggenheim decreased their price objective on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a report on Thursday, August 7th. UBS Group decreased their price objective on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a report on Thursday, August 7th. Finally, Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Nine investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.